Experts said millions of people across the country are prescribed a medicine for moderate to severe acute pain each year, so ...
Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...
( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first ...
The drug offers a non-addictive alternative to opioids, marking 'an important public health milestone in acute pain ...
Vertex Pharmaceuticals (NASDAQ: VRTX) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 ...
Among significant research news last week, US biotech Allakos reported that it was dropping development of its urticaria ...
Lately, one of America's leading pharmaceutical companies can't catch a break from Wall Street. Shares of Vertex ...
A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.